PLIVA SKOPJE Donated Almost 500,000 Macedonian Denars to the Clinic for Radiotherapy and Oncology
As a socially responsible company, a renowned pharmaceutical manufacturer PLIVA donated about 500,000 Macedonian denars for the construction of a special unit at the Clinic for Radiotherapy and Oncology in Skopje which would serve for state-of-the-art preparation of the cytostatic therapy.
"PLIVA and its products were long ago recognized as a trusted and a reliable brand in the segment of pharmaceutical products. Furthermore, as a member of Teva, one of the largest global pharmaceutical companies, PLIVA has been for already three years supplying the Macedonian market with a range of high quality medicinal products for malignant diseases via its distributor ZEGIN. With this donation, we continue to be recognized as a socially responsible company and a respectable manufacturer which builds partnerships and takes care about the communities in which it operates", said Petar Velkoski, Director of PLIVA SKOPJE. Milan Risteski, MD, Director of the Clinic for Radiotherapy and Oncology, thanked PLIVA for recognizing the need for this unit and for its contribution to the modernization of the oncology treatment.
This news aroused a great public interest, and it was published in all Macedonian print and electronic media in the end of December.
With 90 years of successful pharmaceutical experience, PLIVA is today a member of the Teva Group, one of the largest pharmaceutical companies in the world. We at PLIVA are dedicated to providing our customers with high quality, affordable medicines for a better quality of life.
As a responsible corporate citizen, PLIVA makes considerable investments in the communities in which it operates via its charitable donations program and public health actions, which directly contribute to healthcare improvement.